title: Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches.
authors.affiliation: Hospices Civils de Lyon, Institut de Parasitologie et mycologie médicale, Hôpital de la Croix Rousse, Lyon, France.
authors.forename: Francois
authors.initials: F
authors.lastname: Peyron
authors.affiliation: Department of Ophthalmology and Visual Science, Department of Pediatrics (Infectious Diseases), The University of Chicago, Chicago, Illinois, United States of America.|Toxoplasmosis Center, Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America.|Global Health Center, CHeSS, The University of Chicago, Chicago, Illinois, United States of America.
authors.forename: Rima
authors.initials: R
authors.lastname: Mc Leod
authors.affiliation: Centre National de Référence (CNR) Toxoplasmose / Toxoplasma Biological Resource Center (BRC), Centre Hospitalier-Universitaire Dupuytren, Limoges, France.|INSERM UMR 1094, Neuroépidémiologie Tropicale, Laboratoire de Parasitologie-Mycologie, Faculté de Médecine, Université de Limoges, Limoges, France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Ajzenberg
authors.affiliation: Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America.
authors.forename: Despina
authors.initials: D
authors.lastname: Contopoulos-Ioannidis
authors.affiliation: Neonatal Intensive Care Unit, Armand Trousseau Hospital-Assistance Publique-Hopitaux de Paris, Paris, France.
authors.forename: François
authors.initials: F
authors.lastname: Kieffer
authors.affiliation: Hopital Louis Mourier, Assistance Publique-Hopitaux de Paris, Colombes, France.|Centre de Recherche en Epidémiologie et Sante des Populations, INSERM U1018, Le Kremlin-Bicêtre, France, Université Paris Diderot-Paris 7, Paris, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Mandelbrot
authors.affiliation: Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
authors.forename: L David
authors.initials: LD
authors.lastname: Sibley
authors.affiliation: Parasitologie-Mycologie Pole Biologie, CHU A. Michallon, Grenoble, France.|UMR 5163 CNRS/Université Grenoble Alpes, Grenoble, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Pelloux
authors.affiliation: Laboratoire de Parasitologie-Mycologie, Centre National de Référence de la Toxoplasmose, Centre de Ressources Biologiques Toxoplasma, Hôpital Maison Blanche Reims, France.|EA 3800, SFR CAP-SANTE, Université Champagne-Ardenne, Reims, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Villena
authors.affiliation: Hospices Civils de Lyon, Institut de Parasitologie et mycologie médicale, Hôpital de la Croix Rousse, Lyon, France.|Physiologie intégrée du système d'éveil Centre de recherche en neurosciences de Lyon, INSERM U1028-CNRS UMR 5292, Lyon, France.
authors.forename: Martine
authors.initials: M
authors.lastname: Wallon
authors.affiliation: Department of Medicine and Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America.|Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America.
authors.forename: Jose G
authors.initials: JG
authors.lastname: Montoya
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000453:epidemiology* / Q000469:parasitology* / Q000628:therapy; D011379:Prognosis; D016036:Seroepidemiologic Studies; D014122:Toxoplasma / Q000235:genetics / Q000302:isolation & purification; D014125:Toxoplasmosis, Congenital / Q000453:epidemiology* / Q000469:parasitology* / Q000628:therapy; D014481:United States / Q000453:epidemiology
chemical_list: D000981:Antiprotozoal Agents